Heart Failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with heart failure according to the current guidelines and treated with medications regularly; (n=50) 2. Patients without cardiovascular disease but with controllable cardiovascular risk factors, such as hypertension, dyslipidemia, and diabetes; (n=50) 3. Healthy individuals 35 years or older, non-smoker, without cardiovascular disease or risk factor; (n=50) 4. Signed on the informed consent.
Exclusion criteria
Exclusion criteria: 1. Allergic or contraindicated to contrast agent; 2. Other serious cerebrovascular events, such as stroke or transient ischemic attack, have occurred within the last three months; 3. Patients with malignant tumors or multiple organ failure that may not have long-term survival; 4. Suffer from cognitive dysfunction, substance dependence, or severe mental illness; 5. Intravenous drug addicts; 6. Pregnant or lactating women, or planning to be pregnant or donate eggs during study period; 7. The researcher deems it inappropriate to participate in the clinical trial for any reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| myocardial blood flow, MBF;retinal microcirculation; | — |
Countries
China
Contacts
The First Affiliated Hospital of Sun Yat-sen University